COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
- 1 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Infection
- Vol. 49 (4), 677-684
- https://doi.org/10.1007/s15010-021-01587-9
Abstract
Olfactory and gustatory dysfunctions (OGD) are a frequent symptom of coronavirus disease 2019 (COVID-19). It has been proposed that the neuroinvasive potential of the novel SARS-CoV-2 could be due to olfactory bulb invasion, conversely studies suggest it could be a good prognostic factor. The aim of the current study was to investigate the prognosis value of OGD in COVID-19. These symptoms were recorded on admission from a cohort study of 5868 patients with confirmed or highly suspected COVID-19 infection included in the multicenter international HOPE Registry (NCT04334291). There was statistical relation in multivariate analysis for OGD in gender, more frequent in female 12.41% vs 8.67% in male, related to age, more frequent under 65 years, presence of hypertension, dyslipidemia, diabetes, smoke, renal insufficiency, lung, heart, cancer and neurological disease. We did not find statistical differences in pregnant (p = 0.505), patient suffering cognitive (p = 0.484), liver (p = 0.1) or immune disease (p = 0.32). There was inverse relation (protective) between OGD and prone positioning (0.005) and death (< 0.0001), but no with ICU (0.165) or mechanical ventilation (0.292). On univariable logistic regression, OGD was found to be inversely related to death in COVID-19 patients. The odds ratio was 0.26 (0.15–0.44) (p < 0.001) and Z was − 5.05. The presence of anosmia is fundamental in the diagnosis of SARS.CoV-2 infection, but also could be important in classifying patients and in therapeutic decisions. Even more knowing that it is an early symptom of the disease. Knowing that other situations as being Afro-American or Latino-American, hypertension, renal insufficiency, or increase of C-reactive protein (CRP) imply a worse prognosis we can make a clinical score to estimate the vital prognosis of the patient. The exact pathogenesis of SARS-CoV-2 that causes olfactory and gustative disorders remains unknown but seems related to the prognosis. This point is fundamental, insomuch as could be a plausible way to find a treatment.Keywords
This publication has 36 references indexed in Scilit:
- H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep–wake regulatory neurons in miceProceedings of the National Academy of Sciences of the United States of America, 2015
- A lifetime of neurogenesis in the olfactory systemFrontiers in Neuroscience, 2014
- Innate immune responses and neuroepithelial degeneration and regeneration in the mouse olfactory mucosa induced by intranasal administration of Poly(I:C).Cell and tissue research, 2014
- The role of TNF‐α in inflammatory olfactory lossThe Laryngoscope, 2011
- Host strategies against virus entry via the olfactory systemVirulence, 2011
- Neuroinflammation resulting from covert brain invasion by common viruses – A potential role in local and global neurodegenerationMedical Hypotheses, 2010
- Satratoxin G from the Black Mold Stachybotrys chartarum Evokes Olfactory Sensory Neuron Loss and Inflammation in the Murine Noseand BrainEnvironmental Health Perspectives, 2006
- Functional Consequences Following Infection of the Olfactory System by Intranasal Infusion of the Olfactory Bulb Line Varient (OBLV) of Mouse Hepatitis Strain JHMChemical Senses, 2001
- Multiple Regulatory Domains Control IRF-7 Activity in Response to Virus InfectionOnline Journal of Public Health Informatics, 2000
- Neurogenesis and neuron regeneration in the olfactory system of mammals. II. Degeneration and reconstitution of the olfactory sensory neurons after axotomyJournal of Neurocytology, 1979